ZZZhiyuan Zhang

Zhiyuan Zhang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Zhiyuan Zhang has a total of 135 co-authors. Here are the top co-authors by number of shared publications:

  • Xiuli Zhang

    Oral Bioengineering Lab, Shanghai Research Institute of Stomatology, Ninth People's Hospital Affiliated to Shanghai Jiao Tong University, School of Medicine, Shanghai 200011, China

    8 shared publications
  • Jun Zhao

    Department of Orthodontics, Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai Key Laboratory of Stomatology, National Clinical Research Center of Stomatology, Shanghai, China

    6 shared publications
  • Shaoyi Wang

    Department of Oral Surgery, Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai Key Laboratory of Stomatology, National Clinical Research Center of Stomatology, Shanghai, China

    6 shared publications
  • Xinquan Jiang

    Department of Prosthodontics, Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai Key Laboratory of Stomatology, National Clinical Research Center of Stomatology, Shanghai, China

    6 shared publications
  • Ping Zhang

    Department of Oral and Maxillofacial Surgery, Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200011, China

    5 shared publications
  • Qin Xu

    Department of Oral Maxillofacial & Head and Neck Oncology, Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

    5 shared publications

Latest Publications

  • Proteolytic Release of the p75NTR Intracellular Domain by ADAM10 Promotes Metastasis and Resistance to Anoikis

    by Xin Bao, Jianbo Shi, Furong Xie, Zengying Liu, Jingshuang Yu, Wan-Tao Chen, Zhiyuan Zhang, Qin Xu

    Resistance to anoikis allows cancer cells to survive during systemic circulation; however, the mechanism underlying anoikis resistance remains unclear. Here we show that A disintegrin and metalloprotease 10 (ADAM10)–mediated cleavage of p75 neurotrophin receptor (p75NTR) and subsequent generation of the p75NTR intracellular domain (ICD) endow cancer cells with resistance to anoikis. p75NTR ICD promoted expression of TNF receptor–associated factor 6 (TRAF6), a critical intermediary in p75NTR ICD–mediated signal transduction, at the translational level. Cell detachment–induced activation of EGFR triggered autoubiquitination of TRAF6 by facilitating its dimerization, subsequently activated NFκB, and eventually led to anoikis resistance. ADAM10 and p75NTR ICD also promoted tumor metastasis formation in vivo. Together, our findings uncover a previously unknown function for the ADAM10-p75NTR ICD-TRAF6-NFκB axis in preventing anoikis and suggest ADAM10 and p75NTR ICD as potential cancer therapeutic targets. Significance: These findings identify the ADAM10-p75NTR ICD-TRAF6-NFκB signaling axis as a potential candidate for cancer therapy. Cancer Res; 78(9); 2262–76. ©2018 AACR.


  • Open Access

    Growth differentiation factor 15 promotes blood vessel growth by stimulating cell cycle progression in repair of critical-sized calvarial defect

    by Shaoyi Wang, Mengyu Li, Wenjie Zhang, Hongfei Hua, Ningtao Wang, Jun Zhao, Jing Ge, Xinquan Jiang, Zhiyuan Zhang, Dongxia Ye, et al.

    Repair of large bone defects remains a challenge for surgeons, tissue engineering represents a promising approach. However, the use of this technique is limited by delayed vascularization in central regions of the scaffold. Growth differentiation factor 15(GDF15) has recently been reported to be a potential angiogenic cytokine and has an ability to promote the proliferation of human umbilical vein endothelial cells(HUVECs). Whether it can be applied for promoting vascularized bone regeneration is still unknown. In this study, we demonstrated that GDF15 augmented the expression of cyclins D1 and E, induced Rb phosphorylation and E2F-1 nuclear translocation, as well as increased HUVECs proliferation. Furthermore, we also observed that GDF15 promoted the formation of functional vessels at an artificially-induced angiogenic site, and remarkably improved the healing in the repair of critical-sized calvarial defects. Our results confirm the essential role of GDF15 in angiogenesis and suggest its potential beneficial use in regenerative medicine.


  • Open Access

    Disruption and inactivation of the PP2A complex promotes the proliferation and angiogenesis of hemangioma endothelial cells through activating AKT and ERK

    by Furong Xie, Xin Bao, Jingshuang Yu, Wantao Chen, Lizhen Wang, Zhiyuan Zhang, Qin Xu

    Disruption and inactivation of the PP2A complex promotes the proliferation and angiogenesis of hemangioma endothelial cells through activating AKT and ERK


  • Open Access

    Pulsed dye laser therapy for infantile hemangiomas: a systemic review and meta-analysis

    by L. Shen, G. Zhou, J. Zhao, P. Li, Q. Xu, Y. Dong, Z. Zhang

    Background: Infantile hemangiomas (IH) are common pediatric tumors. This meta-analysis was performed to review the therapeutic efficacy and safety of pulsed dye laser (PDL) in the treatment of IH. Methods: Seven databases were searched, including PubMed, OvidSP, Karger, Elsevier, EMBASE, Web of Science and Wiley Online Library. The review collected the characteristics of year of publication, hemangiomas cases, prior treatment, laser parameters, adverse side, pretreatment symptom, and number of response from all articles. Results: A total of 1580 studies were identified, the first round search retrieved 39 articles met inclusion criteria. Of those, only 13 articles with 1529 hemangiomas were included in the meta-analysis. This meta-analysis demonstrated an overall resolution rate of 89.1% with 6.28% incidence of adverse effect. Conclusion: PDL may be the effective modality to decrease the proliferative phase and accelerate rates of involution and resolution with few adverse events.


  • Effect of nano-structured bioceramic surface on osteogenic differentiation of adipose derived stem cells

    by Lunguo Xia, Kaili Lin, Xinquan Jiang, Bing Fang, Yuanjin Xu, Jiaqiang Liu, Deliang Zeng, Maolin Zhang, Xiuli Zhang, Jiang Chang, et al.


  • Comprehensive Evaluation of Cryopreserved Bone‐Derived Osteoblasts for the Repair of Segmental Mandibular Defects in Canines

    by Shaoyi Wang, Jun Zhao, Dongxia Ye, Xiaochen Zhang, Duohong Zou, Xiuli Zhang, Xiaojuan Sun, Shuyang Sun, Weijie Zhang, Chi Yang, et al.

    Background: The repair of segmental mandibular defects remains challenging in the clinic. Previous studies have shown that cryopreserved bone‐derived osteoblasts (CBOs) have good proliferation and osteogenicity. However, whether these cells can be used in the repair of segmental mandibular defects is largely unknown.Purpose: In this study, we applied CBOs combined with beta‐tricalcium phosphate (β‐TCP) to repair a segmental mandibular defect in canines and thus established the feasibility of using this type of tissue‐bank cell for the repair of large bone defects in the future.Material and Methods: Sixteen segmental mandibular defects in 16 animals were made on the right side. Sequential radiographs, computer tomography, polychrome fluorescent labeling, immunohistochemical staining, and histological analysis were used to evaluate the effects of tissue‐engineered bone for segmental mandibular defects.Results: Our results demonstrated that CBOs combined with β‐TCP promoted bone mineralization and deposition at the early stage, and bony union was achieved in the CBO and fresh bone‐derived osteoblast (FBO) groups. However, nonunion and minimal callus were present in the β‐TCP group. Furthermore, there was a large amount of newly formed bone in the CBO and FBO groups and in the autogenous bone group. Additionally, osteocalcin immunohistochemistry showed intensive osteocalcin immunoreactivity in the bone matrix of the CBO and FBO groups.Conclusions: These data indicate that CBOs implanted in a scaffold can promote new bone formation, and this tissue‐engineered bone can repair critically sized segmental mandibular defects in canines. The use of CBOs combined with β‐TCP may be an effective approach for the reconstruction of segmental mandibular defects in the clinic.


  • Enhanced osteogenesis through nano-structured surface design of macroporous hydroxyapatite bioceramic scaffolds via activation of ERK and p38 MAPK signaling pathways

    by Lunguo Xia, Kaili Lin, Xinquan Jiang, Yuanjin Xu, Maolin Zhang, Jiang Chang, Zhiyuan Zhang

    The design of the three-dimensional (3D) porous structures and surface morphological/topographies of implants is considered as a novel approach to enhance the bioactivity and osteoinductive ability in the field of bone regeneration. In the present study, highly interconnective macroporous hydroxyapatite (HAp) bioceramic scaffolds with nanosheet, nanorod and micro-nano-hybrid (the hybrid of nanorod and microrod) surface topographies were fabricated using α-tricalcium phosphate (α-TCP) ceramic scaffolds as precursors, through regulation of the hydrothermal reaction conditions. Moreover, the effects of these three surface topographies on attachment, proliferation and osteogenic differentiation of rat bone marrow stromal cells (bMSCs) as well as the related mechanisms were systematically investigated. The results showed that the HAp bioceramics with these micro-/nano-topography surfaces significantly enhanced cell attachment, cell viability, alkaline phosphatase (ALP) activity, and mRNA expression levels of osteoblast-related genes of bMSCs. In particular, the biomimetic feature of the micro-nano-hybrid topography surface possessed the highest stimulatory effect. The activation in extracellular signal-related kinases (ERK), and p38 mitogen-activated protein kinase (MAPK) signaling pathways was observed in bMSCs cultured on HAp bioceramics with micro-/nano-topography surfaces especially for the micro-nano-hybrid topography surface, and these enhancement effects could be blocked by ERK inhibitor PD98059, and P38 inhibitor SB203580, respectively. Moreover, the in vivo bone regeneration results of rat critical-sized calvarial defect models confirmed that macroporous HAp bioceramics with these micro-/nano-topography surfaces could promote new bone formation and mineralization as compared with the control HAp bioceramic with traditional smooth surfaces, while the scaffold with a micro-nano-hybrid surface could achieve a better effect. The study suggests that the hierarchical micro-nano-hybrid topography shows immense potential in improving the clinical performance of macroporous HAp bioceramics.


  • Open Access

    Enhanced Dentin-Like Mineralized Tissue Formation by AdShh-Transfected Human Dental Pulp Cells and Porous Calcium Phosphate Cement

    by Lunguo Xia, Maolin Zhang, Qing Chang, Lizhen Wang, Deliang Zeng, Xiuli Zhang, Zhiyuan Zhang, Xinquan Jiang

    The aim of the present study was to investigate the effect of Sonic hedgehog (Shh) on human dental pulp cells (hDPCs) and the potential of complexes with Shh gene modified hDPCs and porous calcium phosphate cement (CPC) for mineralized tissue formation. hDPCs were cultured and transfected with adenoviral mediated human Shh gene (AdShh). Overexpression of Shh and cell proliferation was tested by real-time PCR analysis, western blotting analysis, and MTT analysis, respectively. The odontoblastic differentiation was assessed by alkaline phosphatase (ALP) activity and real-time PCR analysis on markers of Patched-1 (Ptc-1), Smoothened (Smo), Gli 1, Gli 2, Gli 3, osteocalcin (OCN), dentin matrix protein-1 (DMP-1), and dentin sialophosphoprotein (DSPP). Finally, AdShh-transfected hDPCs were combined with porous CPC and placed subcutaneously in nude mice for 8 and 12 weeks, while AdEGFP-transfected and untransfected hDPCs were treated as control groups. Results indicated that Shh could promote proliferation and odontoblastic differentiation of hDPCs, while Shh/Gli 1 signaling pathway played a key role in this process. Importantly, more mineralized tissue formation was observed in combination with AdShh transfected hDPCs and porous CPC, moreover, the mineralized tissue exhibited dentin-like features such as structures similar to dentin-pulp complex and the positive staining for DSPP protein similar to the tooth tissue. These results suggested that the constructs with AdShh-transfected hDPCs and porous CPC might be a better alternative for dental tissue regeneration.


  • Inhibitory Effect of the HPV-16mE6Delta/mE7/TBhsp70Delta Vaccine on Oral Squamous Cell Carcinoma

    by Dongxia Ye, Kuijie Wei, Lei Zhang, Qian Jiang, Xiaojian Zhou, Laiping Zhong, Zhiyuan Zhang, Qingzheng Zhao


  • Open Access

    Trehalose Maintains Bioactivity and Promotes Sustained Release of BMP-2 from Lyophilized CDHA Scaffolds for Enhanced Osteogenesis In Vitro and In Vivo

    by Jun Zhao, Shaoyi Wang, Jianqiang Bao, Xiaojuan Sun, Xiaochen Zhang, Xiuli Zhang, Dongxia Ye, Jie Wei, Changsheng Liu, Xinquan Jiang, et al.

    Calcium phosphate (Ca-P) scaffolds have been widely employed as a supportive matrix and delivery system for bone tissue engineering. Previous studies using osteoinductive growth factors loaded Ca-P scaffolds via passive adsorption often experience issues associated with easy inactivation and uncontrolled release. In present study, a new delivery system was fabricated using bone morphogenetic protein-2 (BMP-2) loaded calcium-deficient hydroxyapatite (CDHA) scaffold by lyophilization with addition of trehalose. The in vitro osteogenesis effects of this formulation were compared with lyophilized BMP-2/CDHA construct without trehalose and absorbed BMP-2/CDHA constructs with or without trehalose. The release characteristics and alkaline phosphatase (ALP) activity analyses showed that addition of trehalose could sufficiently protect BMP-2 bioactivity during lyophilization and achieve sustained BMP-2 release from lyophilized CDHA construct in vitro and in vivo. However, absorbed BMP-2/CDHA constructs with or without trehalose showed similar BMP-2 bioactivity and presented a burst release. Quantitative real-time PCR (RT-qPCR) and enzyme-linked immunosorbent assay (ELISA) demonstrated that lyophilized BMP-2/CDHA construct with trehalose (lyo-tre-BMP-2) promoted osteogenic differentiation of bone marrow stromal cells (bMSCs) significantly and this formulation could preserve over 70% protein bioactivity after 5 weeks storage at 25°C. Micro-computed tomography, histological and fluorescent labeling analyses further demonstrated that lyo-tre-BMP-2 formulation combined with bMSCs led to the most percentage of new bone volume (38.79% ±5.32%) and area (40.71% ±7.14%) as well as the most percentage of fluorochrome stained bone area (alizarin red S: 2.64% ±0.44%, calcein: 6.08% ±1.37%) and mineral apposition rate (4.13±0.62 µm/day) in critical-sized rat cranial defects healing. Biomechanical tests also indicated the maximum stiffness (118.17±15.02 Mpa) and load of fracture (144.67±16.13 N). These results lay a potential framework for future study by using trehalose to preserve growth factor bioactivity and optimize release profile of Ca-P based delivery system for enhanced bone regeneration.